Cargando…
Identification of Genes in Candida glabrata Conferring Altered Responses to Caspofungin, a Cell Wall Synthesis Inhibitor
Candida glabrata is an important human fungal pathogen whose incidence continues to rise. Because many clinical isolates are resistant to azole drugs, the drugs of choice to treat such infections are members of the echinocandin family, although there are increasing reports of resistance to these dru...
Autores principales: | Rosenwald, Anne G., Arora, Gaurav, Ferrandino, Rocco, Gerace, Erica L., Mohammednetej, Maedeh, Nosair, Waseem, Rattila, Shemona, Subic, Amanda Zirzow, Rolfes, Ronda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015946/ https://www.ncbi.nlm.nih.gov/pubmed/27449515 http://dx.doi.org/10.1534/g3.116.032490 |
Ejemplares similares
-
Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection
por: Schelenz, Silke, et al.
Publicado: (2006) -
Cellular apoptosis: An alternative mechanism of action for caspofungin against Candida glabrata
por: Aryamloo, Parisa, et al.
Publicado: (2019) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
por: Yamada, Shoko Merrit, et al.
Publicado: (2016) -
Essential Role for the Phosphatidylinositol 3,5-Bisphosphate Synthesis Complex in Caspofungin Tolerance and Virulence in Candida glabrata
por: Choudhary, Deepak Kumar, et al.
Publicado: (2019) -
Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata
por: Ceballos-Garzon, Andres, et al.
Publicado: (2021)